ADILAdial PharmaceuticalsADIL info
$1.08info-0.92%24h
Global rank36542
Market cap$1.32M
Change 7d8.00%
YTD Performance-42.25%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Adial Pharmaceuticals (ADIL) Stock Overview

    Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

    ADIL Stock Information

    Symbol
    ADIL
    Address
    1180 Seminole TrailCharlottesville, VA 22901United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.adialpharma.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    434 422 9800

    Adial Pharmaceuticals (ADIL) Price Chart

    -
    Value:-

    Adial Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.08
    N/A
    Market Cap
    $1.32M
    N/A
    Shares Outstanding
    1.22M
    N/A
    Employees
    16.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org